Skip to content

LaPAroscopic Low pRessure cOlorectal Surgery

LaPAroscopic Low pRessure cOlorectal Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03813797
Acronym
PAROS
Enrollment
138
Registered
2019-01-23
Start date
2019-01-07
Completion date
2020-06-26
Last updated
2020-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant or Benign Pathology

Keywords

Low Pressure, Laparoscopy, Colectomy, Pneumoperitoneum, AirSeal

Brief summary

Laparoscopy by its mini-invasive character has revolutionized abdominal and colorectal surgery but certain limitations remains (post-operative pain due to pneumoperitoneum, pneumoperitoneum stability, visibility during bleeding, smoke evacuation). The medical device for continuous pressure insufflation during laparoscopic procedures Airseal® would allow the maintenance of pneumoperitoneum at a lower pressure. The stable low pressure (7mmHg) is described in the literature for 15 years as the best way to reduce scapular pain, but until the marketing of Airseal, working at 7mmHg was not possible because the space of work was not stable. Moreover, this device makes it possible to obtain a better vision because of the evacuation of the fumes potentially leading to a reduction in the operating time.

Detailed description

This research focuses on a medical device that allows the surgeon to perform the surgical procedure at a lower pressure than usual. The main objective of this study is to compare the duration of hospitalization of patients with laparoscopic colectomy at low pressure (5-7 mmHg) versus standard pressure (12-15 mmHg) It is a prospective randomized monocentric double blind study

Interventions

DEVICEAirseal®

Medical device set to the mode Airseal®, pressure adjustment between 5 and 7 mmHg

Medical device set to the mode Standard Insufflation, pressure adjustment between 12 and 15 mmHg

Sponsors

University Hospital, Bordeaux
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The study will be carried out: * Blind patient: The patient will not know the group he belongs to, in order to minimize the bias related to the self-evaluation of postoperative pain * Blind for the outpatient evaluator: the surgeon will blindly evaluate the primary endpoint: patient's discharge criteria. This evaluator surgeon will be different from the operator surgeon The blind will minimize the measurement bias.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 * Colonic resection (right or left) performed for benign or malignant pathology * Laparoscopic procedure * Informed consent signed * Social Insurance

Exclusion criteria

* Laparotomy procedure * Associated resection (except appendectomy or liver biopsy * Emergency procedure * Pelvic sepsis * Pregnant or breast-feeding woman. * Persons deprived of liberty or under guardianship * Impossibility for compliance to follow-up

Design outcomes

Primary

MeasureTime frameDescription
Length of postoperative hospital stayFrom surgery to the end of the hospitalization (max 30 days)To determine the length of hospitalization

Secondary

MeasureTime frameDescription
Appreciation of visual quality by surgeonDuring surgeryTo determine the rate of visual quality during surgery: poor, medium or good quality
Impact of the use of microlaparoscopic instrumentsDuring surgeryTo determine the rate of use of the microsurgery microlaparoscopic instruments (3mm)
Rates of conversionDuring surgeryConversion to laparoscopy with standard pressure or conversion to laparotomy
Blood pressure (mmHg)During surgeryTo examine the variation of blood pressure during surgery (at the beginning, middle and at the end)
Cardiac frequency (/ min)During surgeryTo examine the variation of cardiac frequency during surgery (at the beginning, middle and at the end)
Volume replacement (mL)During surgeryTo examine the volume replacement during surgery (at the beginning, middle and at the end)
Driving pressure (mmHg)During surgeryTo examine the variation of drinving pressure during surgery (at the beginning, middle and at the end)
Oxygen saturation (%)During surgeryTo examine the variation of SA02 (%) during surgery (at the beginning, middle and at the end)
Surgery timeDuring surgeryTo determine the surgery time
Surgical and medical morbidityFrom surgery until 30 days (max 45 days)To analyse the cumulative Clavien-Dindo at 30 days
Postoperative pain2 hours, 4 hours, 8 hours and 24 hours after the surgeryPain was evaluated with the Numeric Rating Scale (NRS, from 0 (no pain) to 10 (hurts worst)
Use of analgesicsAn average of 5 days after the surgeryTo evaluate the rate of analgesics administrated (from step1 to step3)
Time before the passage of first stool (days)An average of 5 days after the surgeryTo determine the delay of the laxation and gas response
Time before the passage of first gas (days)An average of 5 days after the surgeryTo determine the delay of the gas response
Time before mobilization (Days before 1st time sitting and standing)An average of 5 days after the surgeryTo determine the delay before mobilization
Quality of cancer surgeryDuring surgeryRate of curative surgery (R0)
Number of lymph nodes examedDuring surgeryNumber of lymph nodes examed during a cancer surgery
Partial pressure of mean expired of carbon dioxide (mmHg)During surgeryTo examine the variation PECO2 (mmHg) during surgery (at the beginning, middle and at the end)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026